Natural Treatment for PTSD with Mushrooms: What Works (2026)

Understanding the PTSD Mechanism: DMN and HPA Axis

Post-Traumatic Stress Disorder (PTSD) is a complex psychiatric condition characterized by intrusive memories, avoidance behaviors, negative alterations in cognition and mood, and marked alterations in arousal and reactivity. At the neurological level, PTSD involves stuck trauma memories that the brain cannot properly process. Two primary systems are implicated in this pathology: the Default Mode Network (DMN) and the Hypothalamic-Pituitary-Adrenal (HPA) axis.

The Default Mode Network (DMN) Hyperactivity

The DMN is a network of interacting brain regions that is active when a person is not focused on the outside world, such as during daydreaming, mind-wandering, and self-referential thought. In individuals with PTSD, the DMN often exhibits aberrant connectivity and hyperactivity [Koch et al., 2016]. This hyperactivity is thought to be responsible for the involuntary replay of trauma memories and the persistent sense of threat. Research by Akiki et al. (2017) suggests that the DMN replays trauma involuntarily, keeping the individual trapped in a cycle of re-experiencing the traumatic event [Patriat et al., 2016].

HPA Axis Dysregulation

The HPA axis is the body's central stress response system, comprising the hypothalamus, pituitary gland, and adrenal glands. In a healthy individual, the HPA axis responds to stress by releasing cortisol, which prepares the body for a "fight or flight" response, and then returns to baseline once the threat has passed. However, in PTSD, the HPA axis becomes dysregulated. Studies have shown that PTSD is associated with altered cortisol levels and an exaggerated response to stress, indicating a chronic state of HPA axis dysfunction [Speer et al., 2019]. This dysregulation contributes to the hyperarousal, emotional numbing, and sleep disturbances seen in PTSD patients [Klaassens et al., 2012]. Childhood trauma, in particular, can lead to long-term HPA axis sensitization and dysregulated cortisol responses in adulthood [Murphy et al., 2022].

Psilocybin: Resetting the DMN and Enhancing Neuroplasticity

Psilocybin, the active compound in magic mushrooms, has emerged as a promising treatment for trauma-related disorders. Its primary mechanism of action involves the serotonin 2A (5-HT2A) receptor, which is densely expressed in the DMN. Psilocybin suppresses DMN activity, creating a window of neuroplasticity that allows for trauma processing [Reinwald et al., 2023]. By temporarily disrupting the rigid patterns of thought associated with PTSD, psilocybin enables patients to confront and integrate traumatic memories without the overwhelming emotional response typically associated with them. This neuroplastic effect is crucial for rewiring the brain and breaking free from the cycle of trauma. For a deeper dive into this mechanism, explore psilocybin neuroplasticity and how mushrooms rewire the brain.

Research indicates that psilocybin-induced DMN hypoconnectivity can lead to long-lasting changes in brain function and symptom relief [Khan et al., 2022]. This mechanism is similar to the effects observed in the MAPS Phase 3 MDMA trial, which found that 67% of participants no longer met PTSD criteria after treatment. While MDMA primarily affects the amygdala and fear response, psilocybin's profound impact on the DMN offers a complementary approach to trauma therapy. The ability of psilocybin to attenuate denial by enhancing self-referential processing in brain networks like the DMN is a key therapeutic aspect [Modlin et al., 2025]. For those interested in the clinical applications, understanding the clinical trial results for psilocybin is essential.

Legal Alternatives: Lion's Mane and Rhodiola for PTSD Support

While psilocybin shows great promise, it remains a controlled substance in many jurisdictions. For those seeking legal, non-psychoactive alternatives, functional mushrooms and adaptogens offer a viable path to symptom management. Lion's Mane (Hericium erinaceus) and Rhodiola rosea are two such supplements that target the underlying mechanisms of PTSD, providing support for neurogenesis, stress regulation, and mood enhancement.

Lion's Mane for Neurogenesis, Cognitive Function, and Anxiety Reduction

Lion's Mane is renowned for its neuroprotective and neurogenic properties. It contains bioactive compounds called hericenones and erinacines, which are known to stimulate the production of Nerve Growth Factor (NGF) and Brain-Derived Neurotrophic Factor (BDNF) [Ryu et al., 2018]. These neurotrophins are crucial for the growth, maintenance, and survival of neurons, playing a vital role in brain plasticity and repair. By promoting hippocampal neurogenesis, Lion's Mane has been shown to reduce anxiety and depressive behaviors in animal models [Rodriguez & Lippi, 2022]. This neuroplastic effect can help counteract the structural changes in the brain caused by chronic stress and trauma, improving cognitive function and emotional resilience. Clinical studies have also indicated that Lion's Mane can improve cognitive function, memory, and reduce symptoms of anxiety and depression in humans [Mori et al., 2009; Nagano et al., 2010]. For a comprehensive overview of its benefits, explore the benefits of Lion's Mane mushroom research. Additionally, its potential to alleviate brain fog is a significant advantage for individuals experiencing cognitive difficulties due to PTSD, as detailed in Lion's Mane and brain fog.

Rhodiola Rosea: An Adaptogen for HPA Axis Regulation and Stress Resilience

Rhodiola rosea is a powerful adaptogen, a class of natural substances that help the body adapt to stress and maintain homeostasis. It works primarily by modulating the HPA axis and balancing cortisol levels, which are often dysregulated in PTSD. Clinical trials have demonstrated that Rhodiola supplementation can significantly reduce self-reported anxiety, stress, and depression [Cropley et al., 2015]. By stabilizing the HPA axis, Rhodiola helps mitigate the hyperarousal, emotional volatility, and fatigue associated with PTSD [Bystritsky et al., 2008]. Its active compounds, rosavins and salidrosides, are believed to contribute to its adaptogenic effects by influencing neurotransmitter levels and protecting against oxidative stress. Rhodiola's ability to enhance mental performance under stress and reduce fatigue makes it a valuable addition to a PTSD management strategy [Darbinyan et al., 2000].

The Secret Shrooomz Protocol: A Synergistic Approach

Combining the neurogenic benefits of Lion's Mane with the stress-regulating properties of Rhodiola creates a synergistic effect that addresses both the structural and hormonal imbalances often seen in PTSD. The Secret Shrooomz protocol is designed to provide comprehensive support for mental well-being, leveraging the power of these natural compounds. Secret Shrooomz products are formulated with high-quality, USA-grown fruiting bodies, ensuring maximum potency and efficacy. Each batch is third-party tested for purity and active compounds, guaranteeing a premium product for our customers.

Comparing Natural Treatments for PTSD

To better understand the different approaches to natural PTSD treatment, we have compiled a comparison of the key mechanisms and benefits of psilocybin, Lion's Mane, and Rhodiola. This table highlights their distinct roles and legal statuses, providing a clear overview for individuals considering these options.

Integrating Natural Treatments into a Holistic Plan

While natural treatments like mushrooms and adaptogens offer significant benefits, they are most effective when integrated into a comprehensive, holistic treatment plan. PTSD is a multifaceted disorder that requires a multi-pronged approach to healing. This may include psychotherapy, lifestyle modifications, and social support.

The Role of Psychotherapy and Integration

Therapies such as Cognitive Behavioral Therapy (CBT), Eye Movement Desensitization and Reprocessing (EMDR), and Somatic Experiencing are foundational to PTSD treatment. These therapies help individuals process traumatic memories, reframe negative thought patterns, and regulate their nervous systems. When combined with natural treatments like psilocybin or Lion's Mane, psychotherapy can be even more effective. For instance, the neuroplasticity induced by these substances can make the brain more receptive to the therapeutic process, accelerating healing and integration. If you are considering psilocybin therapy, it is crucial to understand the clinical trial results for psilocybin and how it compares to conventional treatments like SSRIs, as discussed in Psilocybin vs. SSRIs: Head-to-Head Trial Results. Furthermore, for those exploring microdosing, insights from how to start microdosing psilocybin: science-based protocol can be invaluable.

Lifestyle Modifications and Complementary Practices

Diet, exercise, and sleep play a critical role in managing PTSD symptoms. A nutrient-dense diet supports brain health and reduces inflammation, which is often elevated in individuals with PTSD. Regular physical activity helps regulate the HPA axis, release endorphins, and improve sleep quality. Adequate sleep is essential for emotional regulation and cognitive function. Incorporating mindfulness practices, such as meditation and yoga, can also help calm the nervous system and reduce hyperarousal. These practices, combined with the neurobiological support from supplements, create a powerful synergy for recovery.

Frequently Asked Questions (FAQ)

Can I take Lion's Mane and Rhodiola together?

Yes, Lion's Mane and Rhodiola can be taken together. In fact, they are often combined in supplements like Secret Shrooomz because their effects are complementary. Lion's Mane supports brain health and neurogenesis, while Rhodiola helps regulate the body's stress response, making them an excellent combination for overall mental well-being and stress resilience.

How long does it take for Lion's Mane to work for anxiety?

The effects of Lion's Mane on anxiety and mood are typically cumulative. While some people may notice subtle improvements within a few days, it generally takes 2 to 4 weeks of consistent daily use to experience significant benefits. This timeframe allows for neurogenesis and structural changes in the brain to occur, leading to more sustained improvements in mood and cognitive function.

Is psilocybin safe for everyone with PTSD?

Psilocybin is not suitable for everyone. Individuals with a personal or family history of psychotic disorders, such as schizophrenia or bipolar disorder, should avoid psilocybin, as it can exacerbate these conditions. Additionally, psilocybin should only be used in a controlled, therapeutic setting under the guidance of trained professionals. Always consult with a healthcare provider before exploring psychedelic therapies to ensure safety and appropriateness for your specific health profile. For those considering microdosing, it's important to understand the distinctions between microdosing vs. antidepressants side effects.

What is the difference between fruiting body and mycelium mushroom supplements?

The fruiting body is the above-ground part of the mushroom (the cap and stem), while the mycelium is the root-like network that grows underground. High-quality supplements, like Secret Shrooomz, prioritize the use of the fruiting body because it contains higher concentrations of the beneficial active compounds, such as beta-glucans and hericenones, which are responsible for the mushroom's therapeutic effects. Mycelium-based products often contain a significant amount of the grain or substrate they were grown on, diluting the active ingredients and potentially reducing efficacy. Learn more about fruiting body vs mycelium mushroom supplements to make informed choices about your supplements.

Can functional mushrooms help with depression related to PTSD?

Yes, functional mushrooms like Lion's Mane, Cordyceps, and Reishi can offer support for depression symptoms often co-occurring with PTSD. Lion's Mane, as discussed, promotes neurogenesis and can improve mood. Cordyceps is known for its energy-boosting and anti-fatigue properties, which can combat the lethargy associated with depression. Reishi, an adaptogenic mushroom, helps reduce stress and improve sleep, both of which are crucial for managing depressive states. While not a direct treatment for depression, these mushrooms can be valuable complementary tools in a holistic approach to mental well-being. For more on natural approaches to anxiety, see mushroom supplement for anxiety: natural solutions.

References

• [Koch et al., 2016] Koch, S. B. J., van Zuiden, M., Nawijn, L., et al. (2016). Aberrant resting-state brain activity in posttraumatic stress disorder: A meta-analysis and systematic review. Depression and Anxiety, 33(10), 915-926.
• [Akiki et al., 2017] Akiki, T. J., Averill, C. L., & Abdallah, C. G. (2017). A network-based neurobiological model of PTSD: evidence from structural and functional neuroimaging studies. Current Psychiatry Reports, 19(10), 73.
• [Patriat et al., 2016] Patriat, R., et al. (2016). Default-Mode Network Abnormalities in Pediatric Posttraumatic Stress Disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 55(3), 209-218.
• [Speer et al., 2019] Speer, K. E., Semple, S., Naumovski, N., & D'Cunha, N. M. (2019). HPA axis function and diurnal cortisol in post-traumatic stress disorder: A systematic review. Neurobiology of Stress, 11, 100174.
• [Klaassens et al., 2012] Klaassens, E. R., Giltay, E. J., Cuijpers, P., & Van Veen, T. (2012). Adulthood trauma and HPA-axis functioning in healthy subjects and PTSD patients: a meta-analysis. Psychoneuroendocrinology, 37(12), 1951-1961.
• [Murphy et al., 2022] Murphy, F., et al. (2022). Childhood Trauma, the HPA Axis and Psychiatric Illnesses. Frontiers in Psychiatry, 13, 748372.
• [Reinwald et al., 2023] Reinwald, J. R., Schmitz, C. N., Skorodumov, I., et al. (2023). Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats. Translational Psychiatry, 13(1), 358.
• [Khan et al., 2022] Khan, A. J., Bradley, E., & O'Donovan, A. (2022). Psilocybin for trauma-related disorders. In Disruptive Psychopharmacology (pp. 209-226). Springer.
• [Modlin et al., 2025] Modlin, N. L., et al. (2025). Clinical conceptualisation of PTSD in psilocybin treatment. Journal of Psychedelic Studies, 9(1), 1-10.
• [Ryu et al., 2018] Ryu, S., Kim, H. G., Kim, J. Y., Kim, S. Y., & Cho, S. H. (2018). Hericium erinaceus Extract Reduces Anxiety and Depressive Behaviors by Promoting Hippocampal Neurogenesis in the Adult Mouse Brain. Journal of Medicinal Food, 21(2), 174-180.
• [Rodriguez & Lippi, S. L. P., 2022] Rodriguez, M. N., & Lippi, S. L. P. (2022). Lion's Mane (Hericium erinaceus) Exerts Anxiolytic Effects in the rTg4510 Tau Mouse Model. Behavioral Sciences, 12(7), 235.
• [Mori et al., 2009] Mori, K., Inatomi, S., Ouchi, K., Azumi, Y., & Tuchida, I. (2009). Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy Research, 23(3), 367-372.
• [Nagano et al., 2010] Nagano, M., Shimizu, K., Kondo, R., Hayashi, C., Sato, D., Kitajima, K., & Ohnuki, K. (2010). Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomedical Research, 31(4), 231-237.
• [Cropley et al., 2015] Cropley, M., Banks, A. P., & Boyle, J. (2015). The effects of Rhodiola rosea L. extract on anxiety, stress, cognition and other mood symptoms. Phytotherapy Research, 29(12), 1934-1939.
• [Bystritsky et al., 2008] Bystritsky, A., Kerwin, L., & Feusner, J. D. (2008). A pilot study of Rhodiola rosea (Rhodax®) for generalized anxiety disorder (GAD). Journal of Alternative and Complementary Medicine, 14(2), 175-180.
• [Darbinyan et al., 2000] Darbinyan, V., Kteyan, A., Panossian, A., Gabrielian, E., Wikman, G., & Wagner, H. (2000). Rhodiola rosea in stress induced fatigue—a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine, 7(5), 365-371.